Skip to content
healthcare.dev

Thiotepa

NDC 0143-9565, Thiotepa, injection, powder, lyophilized, for solution, from Hikma Pharmaceuticals USA Inc..

Product NDC
0143-9565
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075547
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9565 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • THIOTEPA15 mg/1.5mL

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
0143-9565-01001439565011 VIAL in 1 BOX, UNIT-DOSE (0143-9565-01) / 1.5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b19b03db-471d-4ee7-b1b8-6eccc39c41b0
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0143-9565

Use it

Look up 0143-9565 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9565 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0143-9565. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.